Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression patterns in caecal lamina propria mononuclear cells and epithelial cells following preventive administration of T. suis ova in a rabbit model of DSS colitis

ABSTRACT: We describe the transcriptional changes occurring in lamina propria mononuclear cells (LPMC) and intestinal epithelial cells (IEC) upon Trichuris suis ova (TSO) treatment in a rabbit model of DSS colitis

ORGANISM(S): Oryctolagus cuniculus

PROVIDER: GSE77372 | GEO | 2017/10/31

SECONDARY ACCESSION(S): PRJNA310179

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Trichuris suis

Project description:Trichuris suis overview

| PRJNA160343 | ENA

Preventive Trichuris suis ova (TSO) treatment protects immunocompetent rabbits from DSS colitis but may be detrimental under conditions of immunosuppression.

Project description:Trichuris suis ova (TSO) have been tested for therapeutic application in inflammatory bowel diseases (IBD) yet understanding of the underlying mechanisms and safety in an immunocompromised host is limited due to lack of a suitable animal model. We used a recently established rabbit model of dextran sodium sulphate (DSS) induced colitis to study the efficacy, mechanisms and safety of TSO therapy in immunocompetent and immunosuppressed animals. TSO treatment prevented the DSS induced weight loss, delayed the onset of DSS induced symptoms by 2 days and significantly reduced the disease activity (DAI). TSO treatment protected caecal histology and prevented the colitis-associated loss in faecal microbiota diversity. Mainly the transcriptome of lamina propria mononuclear cells (LPMC) was affected by TSO treatment, showing dampened innate and adaptive inflammatory responses. The protective effect of TSO was lost in immunosuppressed rabbits, where TSO exacerbated colitis. Our data show that preventive TSO treatment ameliorates colitis severity in immunocompetent rabbits, modulates LPMC immune responses and reduces faecal dysbiosis. In contrast, the same TSO treatment exacerbates colitis in immunosuppressed animals. Our data provide further evidence for a therapeutic effect of TSO in IBD, yet caution is required with regard to TSO treatment in immunosuppressed patients.

| S-EPMC5705695 | biostudies-literature

Trichuris suis

Project description:Trichuris suis Genome sequencing and assembly

| PRJNA179528 | ENA

Trichuris suis

Project description:Transcriptome of female and male Trichuris suis

| PRJNA343717 | ENA

Trichuris suis soluble products induce Rab7b expression and limit TLR4 responses in human dendritic cells

Project description:Inflammatory immune disorders such as inflammatory bowel disease (IBD) and multiple sclerosis (MS) are major health problems. Currently, the intestinal whipworm Trichuris suis is being explored in clinical trials to reduce inflammation in these diseases, however, the mechanisms by which the parasite affects the host immune system are not known. Here we determined the effects of T. suis soluble products (SPs) on toll-like receptor-4 (TLR4)-stimulated human dendritic cells (DCs) using Illumina bead chip gene arrays. Pathway analysis of lipopolysaccharide (LPS)-stimulated DCs with or without T. suis treatment showed that costimulation with T. suis SPs resulted in a down-regulation of both the myeloid differentiation primary response gene 88 (MyD88)-dependent and the TIR-domain-containing adaptor-inducing interferon-β (TRIF)-dependent signalling pathways triggered by TLR4. These data were verified using quantitative real-time PCR of several key genes within these pathways and/or defining their protein levels. In addition, T. suis SPs induce Rab7b, a negative regulator of TLR4 signalling that interferes with its trafficking, which coincided with a reduced surface expression of TLR4. These data indicate that the mechanism by which T. suis SPs reduce inflammatory responses is through suppression of both TLR4 signalling and surface expression on DCs.

2015-05-01 | E-MTAB-3443 | biostudies-arrayexpress

Expression data from murine caecal tissue

Project description:We aimed to determine the effect of inulin and Trichuris muris infection on mucosal immune pathways in mice.

2020-09-01 | GSE136492 | GEO

Genome-wide transcriptional profiles of biopsies from the MUCUS trial

Project description:The MUCUS clinical trial (https://clinicaltrials.gov: NCT01433471) was established to investigate the effect of Trichuris suis ova on ulcerative colitis patients.

2017-11-11 | GSE96698 | GEO

Expression data from murine RAW264.7 macrophages

Project description:We aimed to determine the effect of inulin and Trichuris suis soluble product (TsSP) on inflammatory gene expression in LPS-induced macrophages.

2020-04-01 | GSE123717 | GEO

Mutation Mapping of 40 Streptococcus suis strains

Project description:Streptococcus suis is an important zoonotic pathogen that can cause meningitis and sepsis in both pigs and humans. In this study,we evaluated the genetic difference of 40 Streptococcus suis strains belonging to various sequence types by comparative genomic hybridization to identify genes associated with the variation in pathogenicity using NimbleGen’s tilling microarray platform. Application of Comparative Phylogenomics to Identify Genetic Differences Relating to Pathogenicity of Streptococcus suis

2014-05-20 | GSE40035 | GEO

Trichuris suis isolate:DCEP-RM93M

Project description:Trichuris suis isolate:DCEP-RM93M Genome sequencing and assembly

| PRJNA208415 | ENA